ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 10 Sep 2018
Last Applicant/ Owned by
Spalenberg 62
Basel
CH
4051
Serial Number
87533027 filed on 18th Jul 2017
Registration Number
N/A
Correspondent Address
Amanda Katzenstein
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
SLENDINE
Research and development in the pharmaceutical and biotechnology fields Dieting pills and powder preparations to promote weight loss and metabolic health; pharmaceutical preparations for treating diabetes, obesity, fatty liver disease and metabolic syndrome
Classification Information
Class [005]
Pharmaceutical Products
Dieting pills and powder preparations to promote weight loss and metabolic health; pharmaceutical preparations for treating diabetes, obesity, fatty liver disease and metabolic syndrome
Class [042]
Computer & Software Services & Scientific Services
Research and development in the pharmaceutical and biotechnology fields
Mark Details
Serial Number
No 87533027
Mark Type
No Service Mark
Attorney Docket Number
No 084878573815
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.01.21 -
Circles that are totally or partially shaded
26.03.21 -
Ovals that are completely or partially shaded
26.17.09 -
Curved line(s), band(s) or bar(s)
Legal History
| Status Date | Action Taken |
|---|---|
| 10th Sep 2018 | ABANDONMENT - NO USE STATEMENT FILED |
| 10th Sep 2018 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| 06th Feb 2018 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 12th Dec 2017 | PUBLISHED FOR OPPOSITION |
| 12th Dec 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 22nd Nov 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 30th Oct 2017 | ASSIGNED TO LIE |
| 18th Oct 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 18th Oct 2017 | EXAMINERS AMENDMENT E-MAILED |
| 18th Oct 2017 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |